Exact raises $245M in follow-on

On June 7, cancer diagnostics company Exact Sciences Corp. (NASDAQ:EXAS) raised $245 million through the sale of 7 million shares at $35 in a follow-on underwritten by Jefferies, BofA Merrill Lynch, ...